Lucendo Alfredo J, Molina-Infante Javier, Arias Ángel, von Arnim Ulrike, Bredenoord Albert J, Bussmann Christian, Amil Dias Jorge, Bove Mogens, González-Cervera Jesús, Larsson Helen, Miehlke Stephan, Papadopoulou Alexandra, Rodríguez-Sánchez Joaquín, Ravelli Alberto, Ronkainen Jukka, Santander Cecilio, Schoepfer Alain M, Storr Martin A, Terreehorst Ingrid, Straumann Alex, Attwood Stephen E
Department of Gastroenterology, Hospital General de Tomelloso, Servicio de Salud de Castilla-La Mancha, Tomelloso, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
United European Gastroenterol J. 2017 Apr;5(3):335-358. doi: 10.1177/2050640616689525. Epub 2017 Jan 23.
Eosinophilic esophagitis (EoE) is one of the most prevalent esophageal diseases and the leading cause of dysphagia and food impaction in children and young adults. This underlines the importance of optimizing diagnosys and treatment of the condition, especially after the increasing amount of knowledge on EoE recently published. Therefore, the UEG, EAACI ESPGHAN, and EUREOS deemed it necessary to update the current guidelines regarding conceptual and epidemiological aspects, diagnosis, and treatment of EoE.
General methodology according to the Appraisal of Guidelines for Research and Evaluation (AGREE) II and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used in order to comply with current standards of evidence assessment in formulation of recommendations. An extensive literature search was conducted up to August 2015 and periodically updated. The working group consisted of gastroenterologists, allergists, pediatricians, otolaryngologists, pathologists, and epidemiologists. Systematic evidence-based reviews were performed based upon relevant clinical questions with respect to patient-important outcomes.
The guidelines include updated concept of EoE, evaluated information on disease epidemiology, risk factors, associated conditions, and natural history of EoE in children and adults. Diagnostic conditions and criteria, the yield of diagnostic and disease monitoring procedures, and evidence-based statements and recommendation on the utility of the several treatment options for patients EoE are provided. Recommendations on how to choose and implement treatment and long-term management are provided based on expert opinion and best clinical practice.
Evidence-based recommendations for EoE diagnosis, treatment modalities, and patients' follow up are proposed in the guideline.
嗜酸性粒细胞性食管炎(EoE)是最常见的食管疾病之一,也是儿童和青年成人吞咽困难及食物嵌塞的主要原因。这凸显了优化该疾病诊断和治疗的重要性,尤其是在近期关于EoE的知识不断增加之后。因此,欧洲胃肠病学联合会(UEG)、欧洲变态反应和临床免疫学会(EAACI)、欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)以及欧洲嗜酸性粒细胞疾病研究组织(EUREOS)认为有必要更新关于EoE概念和流行病学方面、诊断及治疗的现行指南。
为符合制定建议时证据评估的现行标准,采用了依据《研究与评价指南评估》(AGREE)II和《推荐分级的评估、制定与评价》(GRADE)系统的通用方法。截至2015年8月进行了广泛的文献检索,并定期更新。工作组由胃肠病学家、过敏症专科医生、儿科医生、耳鼻喉科医生、病理学家和流行病学家组成。基于与患者重要结局相关的临床问题进行了系统的循证综述。
该指南包括EoE的更新概念,评估了关于儿童和成人EoE疾病流行病学、危险因素、相关病症及自然史的信息。提供了诊断条件和标准、诊断及疾病监测程序的产出,以及关于EoE患者几种治疗选择效用的循证陈述和建议。基于专家意见和最佳临床实践,提供了关于如何选择和实施治疗及长期管理的建议。
该指南提出了关于EoE诊断、治疗方式及患者随访的循证建议。